A6. New drug development (formerly L3)
Poster Session: New Drug Development
Sam Bryson, PhD
Sr. Computational Biologist
Phase Genomics, Inc.
Seattle, Washington, United States
Benjamin Auch, n/a
Phase Genomics, Inc.
Seattle, Washington, United States
Jonas Grove, n/a
Phase Genomics, Inc.
Seattle, Washington, United States
Bradley J. Nelson, n/a
Phase Genomics, Inc.
Seattle, Washington, United States
Demi Glidden, n/a
Phase Genomics, Inc.
Seattle, Washington, United States
Emily Reister, PhD
Phase Genomics, Inc.
Seattle, Washington, United States
Ivan Liachko, PhD
CEO
Phase Genomics, Inc.
Seattle, Washington, United States